Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice
Clinical trial NCT04203693 · COMPLETED
Trial details
- NCT number
- NCT04203693
- Sponsor
- Almirall, S.A.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-10-30
- Primary completion
- 2024-05-02
- Enrollment
- 331
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.